Dimensional Fund Advisors LP Acquires 139,070 Shares of Guardian Pharmacy Services, Inc. $GRDN

Key Points

• Dimensional Fund Advisors increased its Guardian Pharmacy Services stake by 200%, purchasing 139,070 additional shares to reach 208,594 shares valued at approximately $7.855 million.
• Several other institutional investors also increased or initiated positions, including Jennison Associates, which boosted its holdings by 609.5% to 822,784 shares.
• Analysts remain positive, with seven Buy ratings and two Hold ratings, an overall “Moderate Buy” consensus, and an average price target of $43.83. Guardian recently beat quarterly estimates, reporting $0.29 in EPS and $351.77 million in revenue.

Dimensional Fund Advisors LP boosted its holdings in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 200.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 208,594 shares of the company's stock after buying an additional 139,070 shares during the quarter. Dimensional Fund Advisors LP owned about 0.33% of Guardian Pharmacy Services worth $7,855,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of GRDN. Swiss National Bank lifted its position in shares of Guardian Pharmacy Services by 22.9% in the first quarter. Swiss National Bank now owns 48,300 shares of the company's stock worth $1,819,000 after buying an additional 9,000 shares during the last quarter. Jennison Associates LLC boosted its stake in shares of Guardian Pharmacy Services by 609.5% during the 1st quarter. Jennison Associates LLC now owns 822,784 shares of the company's stock worth $30,986,000 after acquiring an additional 706,823 shares in the last quarter. Bessemer Group Inc. acquired a new position in shares of Guardian Pharmacy Services during the 1st quarter valued at about $2,962,000. Bank of New York Mellon Corp increased its holdings in shares of Guardian Pharmacy Services by 3.2% during the 1st quarter. Bank of New York Mellon Corp now owns 69,432 shares of the company's stock valued at $2,615,000 after acquiring an additional 2,177 shares during the last quarter. Finally, Sanctuary Advisors LLC acquired a new position in shares of Guardian Pharmacy Services during the 1st quarter valued at about $1,352,000.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on GRDN shares. Truist Financial boosted their target price on Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a "buy" rating in a report on Wednesday, June 17th. Wall Street Zen upgraded Guardian Pharmacy Services from a "hold" rating to a "buy" rating in a report on Sunday. Bank of America lifted their price target on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a "buy" rating in a research report on Wednesday, June 17th. Weiss Ratings upgraded shares of Guardian Pharmacy Services from a "hold (c)" rating to a "hold (c+)" rating in a research note on Thursday. Finally, Oppenheimer upped their price objective on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an "outperform" rating in a report on Friday. Seven research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $43.83.

Guardian Pharmacy Services Stock Down 6.3%

GRDN opened at $41.06 on Tuesday. The stock's 50 day moving average price is $40.96 and its two-hundred day moving average price is $37.25. The firm has a market capitalization of $2.04 billion, a P/E ratio of 39.86, a price-to-earnings-growth ratio of 2.87 and a beta of 0.11. Guardian Pharmacy Services, Inc. has a 12-month low of $19.30 and a 12-month high of $47.02.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, topping analysts' consensus estimates of $0.26 by $0.03. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%.The company had revenue of $351.77 million during the quarter, compared to analyst estimates of $340.45 million. As a group, analysts anticipate that Guardian Pharmacy Services, Inc. will post 1.18 earnings per share for the current year.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.

Want to see what other hedge funds are holding GRDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source